IDBS – a leader in Pharmaceutical software solutions – joins SAFE-BioPharma Association’s Vendor Partner Program
IDBS announced today that, as a continuing commitment to quality and industry standards, they have joined the SAFE-BioPharma Association Vendor Partner Program. SAFE created and manages the SAFE™ digital identity and signature standard used in the pharmaceutical industry. IDBS will adopt the standard as part of the E-WorkBook suite, including the Electronic Study Management solution (ESM), BioBook™. IDBS are the first ISV and Electronic Lab Notebook (ELN) vendor to join SAFE.
“We are continuing to support the industry standards approach to our products with this commitment,” said Neil Kipling, Chairman and CEO of IDBS Ltd. “The integration of the SAFE standard within the E-WorkBook suite will represent another reason why our solution is industry leading.”
“We are pleased to welcome IDBS to the SAFE Vendor Partner Program,” said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association. “As part of the expanding SAFE community, IDBS will help scientists and others in the life sciences capture, protect and exchange intellectual property information.”
About IDBS
IDBS is a leading provider of integrated software solutions to the life sciences industry. Maximising the value of research data by enabling organisations to capture, store, share and use data efficiently and effectively, whilst protecting intellectual property across the spectrum of discovery activities.
Headquartered in Guildford, UK, IDBS has U.S. offices in California, New Jersey and Massachusetts. IDBS partners with CTC Laboratory Systems in Japan and a network of distributors to market IDBS products and services in Asia. Founded in 1989, IDBS employs more than 150 people worldwide.
About BioBook
Part of the IDBS E-WorkBook Suite, BioBook is an Electronic Study Management Solution that manages the entire lifecycle of complex biological experiments in one place; from design and set-up through data capture, analysis and graphing to report creation, electronic sign-off and publication. BioBook enables scientists to capture IP securely in a 21 CFR Part 11 compliant environment with the added benefit of real-time data sharing, analysis and rapid delivery of reports. BioBook is the leading commercially available solution for complete electronic experiment and study management in a single secure environment
About SAFE-BioPharma Association
SAFE-BioPharma Association is the non-profit association that created and manages the SAFE™ digital identity and signature standard for the pharmaceutical and healthcare industries. Through the SAFE standard, the association promotes interoperability and integration among researchers, vendors, regulators, clinicians and other pharmaceutical and healthcare stakeholders. The SAFE standard provides a secure, enforceable, and regulatory compliant way to verify the identities of parties involved in business-to-business and business-to-regulator electronic transactions. SAFE stands for “Signatures and Authentication For Everyone.” The Association’s founder-members include AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Procter & Gamble, and Sanofi-Aventis. For more information visit www.safe-biopharma.org . SAFE™ is a trademark of SAFE-BioPharma Association.
Any use of this trademark requires approval from SAFE-BioPharma Association.
www.idbs.com
